<< Ironwood Pharmaceuticals files Form 10-K annual report with U.S. Securities and Exchange Commission | INADA introduces new Sogno DreamWave Spa Massage Chair >>
Read in | English | Français | Português | Italiano | 日本語 | 한국어 | 简体中文 | Nederlands | Finnish | Русский | Polski

Ampio Pharmaceuticals receives approval to trade under new stock trading symbol "AMPE"

Published on March 31, 2010 at 5:26 AM · No Comments

Ampio Pharmaceuticals, Inc. (OTC Bulletin Board: AMPE, www.ampiopharma.com), announced it has received approval for a new stock trading symbol from FINRA Operations. Effective March 31, 2010, Ampio Pharmaceuticals, Inc. will trade under the symbol "AMPE," and Ampio's common stock will carry a new CUSIP number,  03209T  109. The symbol change follows the March 24 change in the company's corporate name from Chay Enterprises, Inc. to Ampio Pharmaceuticals, Inc., and its reincorporation in Delaware.  

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading